Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02422797 |
|---|---|
| Brief Title: | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) |
| First Submitted : | April 9, 2015 |
| First Submitted that Met QC Criteria : | April 20, 2015 |
| First Posted : | April 21, 2015 (Estimate) |
| Results First Submitted : | July 27, 2017 |
| Results First Submitted that Met QC Criteria : | September 22, 2017 |
| Results First Posted : | October 24, 2017 |
| Last Update Submitted that Met QC Criteria : | December 3, 2021 |
| Last Update Posted : | December 14, 2021 |